trial · primary record
BI 3968621
Advanced Solid Tumour
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 90 |
| Primary completion | 2030-09-03 |
| Primary endpoint | Occurrence of dose-limiting toxicities (DLTs) during the primary DLT evaluation period (Dose escalation part A and B) |
| Registry ID | NCT07851103 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:42:58.623Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07851103
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.